NYSEMKT: MAIAMaia Biotechnology Inc Stock Ownership - Who owns Maia Biotechnology?
Insider buying vs selling
Have Maia Biotechnology Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Vlad Vitoc | Chief Executive Officer | 2026-06-01 | 72,700 | $1.39 | $100.91kBuy |
| Stan Smith | Director | 2026-06-01 | 75,000 | $1.34 | $100.20kBuy |
| Sergei Gryaznov | Chief Scientific Officer | 2026-06-01 | 2,000 | $1.35 | $2.69kBuy |
| Stan Smith | Director | 2025-12-22 | 57,189 | $1.22 | $70.00kBuy |
| Ngar Yee Louie | Director | 2025-12-22 | 81,699 | $1.22 | $100.00kBuy |
| Steven M. Chaouki | Director | 2025-12-22 | 40,849 | $1.22 | $50.00kBuy |
| Stan Smith | Director | 2025-12-05 | 4,580 | $1.20 | $5.50kBuy |
| Stan Smith | Director | 2025-12-05 | 4,580 | $1.19 | $5.45kBuy |
| Stan Smith | Director | 2025-12-05 | 4,580 | $1.20 | $5.50kBuy |
| Vlad Vitoc | Chief Executive Officer | 2025-11-28 | 50,000 | $1.14 | $56.85kBuy |
MAIA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MAIA insiders and whales buy or sell their stock.
MAIA Shareholders
What type of owners hold Maia Biotechnology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Solas Capital Management LLC | 7.07% | 4,297,004 | $5.37M | Institution |
| Alyeska Investment Group LP | 4.11% | 2,500,000 | $3.13M | Institution |
| Vanguard Capital Management LLC | 3.41% | 2,074,045 | $2.59M | Institution |
| Ngar Yee Louie | 2.05% | 1,248,888 | $1.56M | Insider |
| Vlad Vitoc | 1.95% | 1,186,221 | $1.48M | Insider |
| 683 Capital Management LLC | 1.75% | 1,066,666 | $1.33M | Institution |
| Centric Wealth Management | 1.31% | 796,723 | $995.90k | Institution |
| Cable Car Capital LP | 1.07% | 648,503 | $810.63k | Institution |
| Ramiro Guerrero | 0.97% | 588,218 | $735.27k | Insider |
| Bleichroeder LP | 0.82% | 500,000 | $625.00k | Institution |
MAIA vs Biotech Stocks
Maia Biotechnology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.